SEARCH

SEARCH BY CITATION

References

  • 1
    Health information for travelers to Nicaragua. Atlanta, Centers for Disease Control and Prevention. Available at: http://wwwnc.cdc.gov/travel/destinations/nicaragua.aspx. (Accessed 2010 Jan 14).
  • 2
    Wongsrichanalai C, Barcus MJ, Muth S, et al. A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). Am J Trop Med Hyg 2007; 77(Suppl 6): 119127.
  • 3
    Blaschitz M, Nardoslaysky-Gföller M, Kanzler M, et al. Babesia species occurring in Austrian Ixodes ricinus ticks. Appl Environ Microbiol 2008; 74:48414846.
  • 4
    Nicholas KB, Nicholas HB., Jr, Deerfield II DW. GeneDoc: analysis and visualization of genetic variation. Embnet News 1997; 4:14.
  • 5
    Herwaldt BL, Caccio S, Gherlinzoni F, et al. Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe. Emerg Infect Dis 2003; 9:942948.
  • 6
    World Health Organization. Malaria Treatment Guidelines. 2nd Ed. Geneva: World Health Organization, 2010.
  • 7
    Krause PJ, Lepore T, Sikand VK, et al. Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med 2000; 16343(20):14541458.
  • 8
    Marley SE, Eberhard ML, Steurer FJ, et al. Evaluation of selected antiprotozoal drugs in the Babesia microti-hamster model. Antimicrob Agents Chemother 1997; 41:9194.
  • 9
    Ruebush TK II, Juranek DD, Spielman A, et al. Epidemiology of human babesiosis on Nantucket Island. Am J Trop Med Hyg 1981; 30:937941.